Sonio is a business based in Paris that creates AI-powered software for ultrasound processes. Samsung Medison, a medical device unit of Samsung Electronics that specializes in manufacturing diagnostic imaging devices, announced on Wednesday that it wants to purchase Sonio for around $92.7 million (KRW 126 billion).
The French startup has received regulatory clearance in the United States (FDA 510(k)) for Sonio Detect, a product that uses deep learning algorithms to improve the image quality of ultrasound scans in real time. The AI assistant is intended to assist obstetricians and gynecologists with the evaluation and documentation of ultrasound exams.
Better AI-driven imaging workflows will be available on the market, according to Samsung Medison, with the aid of Sonio’s software. 2011 saw Samsung Electronics pay $22 million to acquire Medison, giving it a 68.45% interest in the medical device division.
In a statement, Samsung claimed that Sonio will continue to operate independently after the acquisition, expand its clientele, and provide goods and services in France.
Sonio, which was co-founded in 2020 by Remi Besson, the CSO, and Cecile Brosset, the CEO, most recently raised $14 million in a Series A led by Cross Border Impact Ventures in August 2023. According to Tracxn, the company has raised $27.2 million in total. Elaia, Bpifrance French Tech Seed, OneRagtime, and a few angel investors are among its backers.
Samsung Medison CEO Yong Kwan Kim stated, “Through the acquisition of Sonio, Samsung Medison will continue to deliver upon our promise to improve the quality of people’s lives with technology,” “Collaboration with Sonio will bring together best-in-class ultrasound AI technology and reporting capabilities to bring a paradigm shift in the prenatal ultrasound exam.”
According to Sonio CEO Brosset,“Samsung Medison’s established global ultrasound business combined with Sonio’s advanced AI creates an exciting growth opportunity for both sides,” “We have found in Samsung Medison an amazing, trusting partner to pursue and accelerate our roadmap and mission. In addition to close collaboration with Samsung Medison, as an independent company, Sonio will continue to advance medical reporting technology and diagnostic software globally, including for underserved areas in healthcare.”
